Inventor
NABEL GARY J
US86 patents
⚠️ This page may combine multiple inventors who share the name “NABEL GARY J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV MICHIGAN
13 patentsUS5698531ADec 16, 1997
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
UNIV MICHIGAN162 citations99
US5328470AJul 12, 1994
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
UNIV MICHIGAN1,197 citations99
US5863904AJan 26, 1999
Methods for treating cancers and restenosis with P21
UNIV MICHIGAN93 citations98
US6218372B1Apr 17, 2001
Methods for treating restenosis with p21
UNIV MICHIGAN70 citations96
US6203991B1Mar 20, 2001
Inhibition of smooth muscle cell migration by heme oxygenase I
UNIV MICHIGAN57 citations96
US6057300AMay 2, 2000
Methods for treating cancers and restenosis with p21
UNIV MICHIGAN56 citations96
US5707969AJan 13, 1998
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
UNIV MICHIGAN73 citations96
US5324818AJun 28, 1994
Proteins useful in the regulation of κB-containing genes
UNIV MICHIGAN111 citations95
US6297219B1Oct 2, 2001
Site-specific instillation of cells or site-specific transformation of cells and kits therefor
UNIV MICHIGAN30 citations92
US6177272B1Jan 23, 2001
Method for treating vascular proliferative diseases with p27 and fusions thereof
UNIV MICHIGAN32 citations92
US7226589B2Jun 5, 2007
Treatment of diseases by site specific instillation of cells or site specific transformation of cells and kits therefor
UNIV MICHIGAN5 citations74
US6818016B1Nov 16, 2004
Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo
UNIV MICHIGAN10 citations74
US6894154B2May 17, 2005
hKIS compositions and methods of use
UNIV MICHIGAN7 citations73
US HEALTH
10 patentsUS7094598B2Aug 22, 2006
Development of a preventive vaccine for filovirus infection in primates
US HEALTH43 citations96
US7947822B2May 24, 2011
HIV vaccines based on Env of multiple clades of HIV
US HEALTH17 citations92
US9441019B2Sep 13, 2016
Influenza hemagglutinin protein-based vaccines
US HEALTH30 citations90
US10369208B2Aug 6, 2019
Methods for the induction of immune responses in a subject compromising administering virus-like particles (VLPS) prepared from Chikungunya virus structural proteins
US HEALTH5 citations84
US10035844B2Jul 31, 2018
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein
US HEALTH6 citations83
US9695230B2Jul 4, 2017
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein
US HEALTH9 citations83
US10137190B2Nov 27, 2018
Nucleic acid molecules encoding ferritin-hemagglutinin fusion proteins
US HEALTH10 citations82
US11718647B2Aug 8, 2023
Virus-like particles and methods of use
US HEALTH2 citations73
US10138277B2Nov 27, 2018
Virus-like particles and methods of use
US HEALTH3 citations73
US7635688B2Dec 22, 2009
Development of a preventive vaccine for filovirus infection in primates
US HEALTH6 citations73
NABEL GARY J
7 patentsUS8454972B2Jun 4, 2013
Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen
NABEL GARY J212 citations98
US9353353B2May 31, 2016
Virus-like particles (VLPs) prepared from chikungunya virus structural proteins
NABEL GARY J29 citations97
US9487563B2Nov 8, 2016
Virus-like particles and methods of use
NABEL GARY J18 citations92
US8106026B2Jan 31, 2012
Development of a preventive vaccine for filovirus infection in primates
NABEL GARY J11 citations92
US8323961B2Dec 4, 2012
HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV
NABEL GARY J13 citations90
US8124592B2Feb 28, 2012
Development of a preventive vaccine for filovirus infection in primates
NABEL GARY J3 citations73
US8106027B2Jan 31, 2012
Development of a preventive vaccine for filovirus infection in primates
NABEL GARY J3 citations73
US NAVY
5 patentsUS7175843B2Feb 13, 2007
Methods for selectively stimulating proliferation of T cells
US NAVY821 citations99
US7144575B2Dec 5, 2006
Methods for selectively stimulating proliferation of T cells
US NAVY799 citations99
US6905680B2Jun 14, 2005
Methods of treating HIV infected subjects
US NAVY879 citations99
US6887466B2May 3, 2005
Methods for selectively stimulating proliferation of T cells
US NAVY914 citations99
US5858358AJan 12, 1999
Methods for selectively stimulating proliferation of T cells
US NAVY885 citations99
SANOFI SA
5 patentsUS10882922B2Jan 5, 2021
Trispecific and/or trivalent binding proteins
SANOFI SA20 citations93
US11192960B2Dec 7, 2021
Trispecific and/or trivalent binding proteins
SANOFI SA6 citations83
US11129905B2Sep 28, 2021
Bivalent, bispecific binding proteins for prevention or treatment of HIV infection
SANOFI SA6 citations83
US11779651B2Oct 10, 2023
Bivalent, bispecific binding proteins for prevention or treatment of HIV infection
SANOFI SA2 citations72
US11613576B2Mar 28, 2023
Trispecific binding proteins, methods, and uses thereof
SANOFI SA3 citations71
GENETICS INST LLC
2 patentsGENETICS INST
2 patentsUS6534055B1Mar 18, 2003
Methods for selectively stimulating proliferation of T cells
GENETICS INST1,025 citations99
US6352694B1Mar 5, 2002
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
GENETICS INST1,159 citations99
MASCOLA JOHN R
2 patentsINST GENETICS LLC
1 patentVICAL INC
1 patentSULLIVAN NANCY J
1 patentTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES
1 patentShowing the top 50 of 86 patents by PatentIndex Score.